Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R 2 ) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Ralph Mangusan, DNP, CRNP, Jomy George, PharmD, Elaine S. Jaffe, MD, Stefania Pittaluga, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Mark Roth, MD, Constance M. Yuan, MD PhD, Hao-Wei Wang, MD PhD, Vickie Ann Marshall, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137188

Published: 2020

Journal Articles

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Kathryn Lurain, MDMPH, Ramya Ramaswami, MBBS,MPH, Anaida Widell, RN, Irene Ekwede, RN, Jomy George, PharmD, Maryalice Stetler-Stevenson, MD PhD, Mark Raffeld, MD, Constance M. Yuan, MD PhD, Joseph Ziegelbauer, PhD, Frank Maldarelli, MD PhD, William D. Figg, PharmD, Cody Peer, PhD, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2019) 134 (Supplement_1): 4096.

https://doi.org/10.1182/blood-2019-122070

Published: 2019

Journal Articles

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

Blood (2019) 134 (Supplement_1): 1540.

https://doi.org/10.1182/blood-2019-131367

Published: 2019

Journal Articles

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

Manoj P. Menon, MD, Victor A. Chow, MD, Adam Greenbaum, MD PhD, Ryan C. Lynch, MD, Mazyar Shadman, MD MPH, Andrei Shustov, MD, Stephen D. Smith, MD, Brian G. Till, MD, Yolanda D. Tseng, MD, Chaitra S. Ujjani, MD, Thomas S. Uldrick, MD MS, Edus H. Warren, MD PhD, Ajay K. Gopal, MD

Blood (2019) 134 (Supplement_1): 4733.

https://doi.org/10.1182/blood-2019-127505

Published: 2019

Journal Articles

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Vickie Marshall, Nazzarena Labo, MD PhD, Anaida Widell, Matthew Lindsley, Mark N. Polizzotto, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 4137.

https://doi.org/10.1182/blood-2018-99-117668

Published: 2018

Journal Articles

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Ramya Ramaswami, MBBS, MPH, Kathryn Lurain, MD MPH, Anaida Widell, Mark N. Polizzotto, Priscila H. Goncalves, MD, Matthew Lindsley, Seth M. Steinberg, PhD, Denise Whitby, Thomas S. Uldrick, MD MS, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 2894.

https://doi.org/10.1182/blood-2018-99-113119

Published: 2018

Journal Articles

Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate

Kathryn Lurain, MD MPH, Thomas S. Uldrick, MD MS, Priscila H. Goncalves, MD, Ramya Ramaswami, MBBS, MPH, Mark N. Polizzotto, Anaida Widell, Seth M. Steinberg, PhD, Elaine S. Jaffe, Stefania Pittaluga, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Constance M. Yuan, MD PhD, Richard F. Little, MD MPH, Robert Yarchoan, MD

Blood (2018) 132 (Supplement 1): 2963.

https://doi.org/10.1182/blood-2018-99-112169

Published: 2018

Journal Articles

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

Chloe Stiggelbout, Megan Real-Hall, Innocent Mutyaba, MBChB, MS, Elizabeth M Krantz, Scott Adams, PhD, Thomas S. Uldrick, MD MS, Jackson Orem, MBChB, MMed, PhD, Corey Casper, MD MPH, Suzanne McGoldrick, MD MPH, Steven Kussick, MD

Blood (2018) 132 (Supplement 1): 2271.

https://doi.org/10.1182/blood-2018-99-116263

Published: 2018

Journal Articles

Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy

Thomas S. Uldrick, MD MS, Manisha Bhutani, MD, Mark N. Polizzotto, MBBS, BMedSc, Karen O. Aleman, RN, Kathleen M. Wyvill, RN, Priscila H. Goncalves, MD, Stefania Pittaluga, MD PhD, Armando Filie, MD, Vickie Marshall, PhD, Adam W Rupert, Giovanna Tosato, MD, Denise Whitby, PhD, Richard F Little, MPH, MD, Seth M. Steinberg, PhD, Robert Yarchoan, MD

Blood (2014) 124 (21): 3001.

https://doi.org/10.1182/blood.V124.21.3001.3001

Published: 2014

Journal Articles

Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection

Mark N. Polizzotto, MBBS, FRACP, FRCPA, Irini Sereti, MD, Thomas S. Uldrick, MD MS, Kathleen M. Wyvill, RN, Stig M. R. Jensen, PhD, Amrit Singh, BSc, Stephen B. Kovacs, BSc, Karen O. Aleman, RN, Vickie Marshall, PhD, Denise Whitby, PhD, Frank Maldarelli, MD PhD, Seth M. Steinberg, PhD, Jerome B. Zeldis, MD PhD, Robert Yarchoan, MD

Blood (2014) 124 (21): 4128.

https://doi.org/10.1182/blood.V124.21.4128.4128

Published: 2014

Journal Articles

Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis.

Thomas S Uldrick, MD, MS, Mark N Polizzotto, MBBS, BMedSc, Armando Filie, MD, Karen Aleman, RN, Kathleen M Wyvill, RN, Richard F Little, MD, MPH, Seth M. Steinberg, PhD, Elaine S Jaffe, MD, Denise Whitby, PhD, Stefania Pittaluga, Robert Yarchoan, MD

Blood (2012) 120 (21): 2708.

https://doi.org/10.1182/blood.V120.21.2708.2708

Published: 2012

Journal Articles

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

Mark N Polizzotto, MBBS, BMedSc, Thomas S Uldrick, MD, MS, Victoria Wang, PhD, Karen Aleman, RN, Kathleen M Wyvill, RN, Vickie Marshall, PhD, Stefania Pittaluga, MD, PhD, Deirdre O'Mahony, MBBS, Denise Whitby, PhD, Giovanna Tosato, PhD, Seth M. Steinberg, PhD, Richard F Little, MD, MPH, Robert Yarchoan, MD

Blood (2011) 118 (21): 1573.

https://doi.org/10.1182/blood.V118.21.1573.1573

Published: 2011

NARROW

Phase I Study of Lenalidomide Combined with Dose-Adjusted EPOCH and Rituximab (EPOCH-R 2 ) in Primary Effusion Lymphoma in Participants with or without HIV (NCT02911142)

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R 2 ) in Primary Effusion Lymphoma in Patients with or without HIV

Natural History Study of Idiopathic Multicentric Castleman Disease Identifies Effective Treatments for a Large Proportion of Patients but Treatment-Refractory Patients Remain

High Rate of Exclusion of HIV Infected Patients from Modern Lymphoma Studies: An Analysis of Current United States Therapeutic Trials

IL-13 Expression Characterizes Effusions Associated with Primary Effusion Lymphoma but Not Other Disorders Caused By Kaposi Sarcoma Herpesvirus (KSHV)

Pilot Study of Tocilizumab in Patients with HIV and Symptomatic Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease

Radiation-Sparing Treatment of HIV-Related Primary Central Nervous System Lymphoma with Antiretroviral Therapy, Rituximab and High-Dose Methotrexate

Pathologic Misdiagnosis in Children with Suspected Burkitt Lymphoma Associated with Early Mortality

Inflammatory Cytokines, Hyperferritinemia and IgE Are Prognostic in Patients with KSHV-Associated Lymphomas Treated with Curative Intent Therapy

Pomalidomide Induces Expansion of Activated and Central Memory CD4+ and CD8+ T Cells in Vivo in Patients with and without HIV Infection

Clinical, Immunologic, and Virologic Findings in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Lymphomas Suggest KSHV-Associated Inflammatory Syndromes Contribute to Symptoms and Disease Pathogenesis.

Distinct Human and Viral Interleukin-6 Profiles and Other Viral and Immunologic Abnormalities In KSHV-Associated Multicentric Castleman Disease: Relationship with Disease Activity and Individual Disease Manifestations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only